Muinelo-Romay, L.; Vieito, M.; Abalo, A.; Nocelo, M.A.; Barón, F.; Anido, U.; Brozos, E.; Vázquez, F.; AguÃn, S.; Abal, M.;
et al. Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment. Cancers 2014, 6, 153-165.
https://doi.org/10.3390/cancers6010153
AMA Style
Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Barón F, Anido U, Brozos E, Vázquez F, AguÃn S, Abal M,
et al. Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment. Cancers. 2014; 6(1):153-165.
https://doi.org/10.3390/cancers6010153
Chicago/Turabian Style
Muinelo-Romay, Laura, Maria Vieito, Alicia Abalo, Marta Alonso Nocelo, Francisco Barón, Urbano Anido, Elena Brozos, Francisca Vázquez, Santiago AguÃn, Miguel Abal,
and et al. 2014. "Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment" Cancers 6, no. 1: 153-165.
https://doi.org/10.3390/cancers6010153
APA Style
Muinelo-Romay, L., Vieito, M., Abalo, A., Nocelo, M. A., Barón, F., Anido, U., Brozos, E., Vázquez, F., AguÃn, S., Abal, M., & López, R. L.
(2014). Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment. Cancers, 6(1), 153-165.
https://doi.org/10.3390/cancers6010153
